Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer
SWOG Cancer Research Network
Mariana Chavez-MacGregor; Jieling Miao; Lajos Pusztai; Matthew P Goetz; Priya Rastogi; Patricia A Ganz; Eleftherios P Mamounas; Soonmyung Paik; Hanna Bandos; Wajeeha Razaq; Anne O'Dea; Virginia Kaklamani; Andrea L M Silber; Lisa E Flaum; Eleni Andreopoulou; Albert G Wendt; Jennifer F Carney; Priyanka Sharma; Julie R Gralow; Danika L Lew; William E Barlow; Gabriel N Hortobagyi
SWOG Statistical Center, Seattle, WA. ; SWOG Statistical Center, Seattle, WA.